An In-Depth Clinical Review of Intermenstrual Bleeding: Causes, Evaluation, and Management

Introduction: Understanding Bleeding Outside of Menstruation

Vaginal bleeding that occurs outside of a regular menstrual period is a common and often concerning symptom.

While it can be caused by a variety of factors, many of which are benign, it can also signal an underlying medical condition that requires evaluation and treatment.

This report provides a comprehensive clinical overview of bleeding between periods, known medically as intermenstrual bleeding (IMB).

It will systematically explore the potential causes, detail the diagnostic process a healthcare provider may undertake, and outline the corresponding management strategies.

The objective is to demystify this symptom, providing a clear, evidence-based framework for understanding its origins and the importance of a thorough medical assessment.

Defining Intermenstrual Bleeding (IMB) and Abnormal Uterine Bleeding (AUB)

The menstrual cycle is a complex, hormonally regulated process that typically lasts between 21 and 35 days.¹

Normal menstrual bleeding, or a period, is the shedding of the uterine lining (endometrium) and can last for up to eight days.³

Any bleeding from the uterus that deviates from an individual’s normal pattern in terms of regularity, volume, frequency, or duration is categorized as Abnormal Uterine Bleeding (AUB).³

Intermenstrual bleeding (IMB) is a specific type of AUB, defined as vaginal bleeding that occurs at any point during the menstrual cycle other than during the expected period.¹

This term is now preferred over older, less precise labels like “metrorrhagia”.⁶

It is essential to distinguish IMB from an irregular menstrual cycle.

An irregular cycle is characterized by unpredictable timing, with the interval between periods being shorter than 21 days or longer than 35 days.¹

In contrast, IMB refers to bleeding episodes that happen

between otherwise predictable menstrual periods.

Experiencing IMB is very common, and most women will have it at some point in their lives.¹

Differentiating Spotting from a Period: A Comparative Analysis

The term “bleeding” can encompass a wide range of experiences, from very light spotting to a flow that mimics a regular period.

Distinguishing between these is a critical first step in characterizing the symptom for a healthcare provider.

The primary differences lie in the volume of blood, its duration and pattern, its appearance, and the presence of associated symptoms.

• Volume: The most significant difference is the quantity of blood. A menstrual period typically requires the use of sanitary products like pads or tampons to manage the flow.⁹ Spotting, on the other hand, produces much less blood and may only be apparent as a few drops on underwear or when wiping with toilet tissue.⁹
• Duration and Pattern: Menstrual bleeding is generally consistent and sustained, lasting from a few days to a week, often following a predictable pattern of starting light, becoming heavier, and then tapering off.² Spotting is frequently irregular and intermittent; it might occur for a day, stop, and then start again, or last for only a few hours.¹¹ Ovulation spotting, for example, typically lasts for only one to two days.¹⁴
• Color and Consistency: The appearance of the blood can also be a clue. Menstrual blood is usually bright to dark red, though it can appear brown at the very beginning or end of a period.⁹ The passage of blood clots is also more common during menstruation.¹¹ Blood from spotting is often a different color, such as light pink, brown, or rust-colored, and may be mixed with normal cervical fluid, giving it a different, sometimes thinner, texture.¹¹
• Associated Symptoms: A regular period is often preceded or accompanied by other symptoms driven by hormonal shifts, such as breast tenderness, headaches, bloating, and uterine cramping.⁹ While some causes of spotting can be associated with mild cramping (such as ovulation spotting or implantation bleeding), it is less commonly linked to the full constellation of premenstrual symptoms.⁹

The subjective nature of these descriptions means that what one person considers “spotting,” another might call “light bleeding.” The most clinically relevant information is not the label applied to the bleeding, but rather its timing relative to the expected period and whether it represents a change from the individual’s established personal pattern.

The Clinical Significance of IMB: Why It Warrants Attention

While often stemming from harmless physiological events, IMB is a symptom that should not be dismissed.¹

It can be the first indication of a range of underlying medical conditions, from treatable infections and hormonal imbalances to structural issues like polyps or fibroids.¹

In less common cases, particularly in older individuals or those with specific risk factors, it can be a sign of a precancerous condition or a gynecological malignancy.²

Beyond the physical implications, the unpredictable nature of IMB can have a significant psychological impact, causing anxiety, stress, and disruption to daily life and intimacy.⁶

Seeking a medical evaluation is therefore important not only to rule out serious pathology and obtain appropriate treatment but also to gain peace of mind and restore a sense of control over one’s health.

Any new, persistent, or worrisome pattern of bleeding between periods warrants a discussion with a healthcare provider.¹

The PALM-COEIN Framework: A Systematic Approach to Causation

To bring clarity and consistency to the diagnosis of abnormal uterine bleeding, the International Federation of Gynecology and Obstetrics (FIGO) developed, and the American College of Obstetricians and Gynecologists (ACOG) has endorsed, a standardized classification system.⁶

This system, known by the acronym PALM-COEIN, represents a significant advancement in gynecological practice.

It moves away from older, often vague descriptive terms like “dysfunctional uterine bleeding” (DUB) and toward a structured, etiology-based framework that helps clinicians systematically investigate the root cause of the bleeding.⁶

This modern approach reflects a deeper understanding that abnormal bleeding is not merely a “dysfunction” but a symptom with a specific, identifiable cause that must be diagnosed to be properly managed.

The PALM-COEIN system categorizes the potential causes of AUB into two primary groups: structural causes, which are anatomical abnormalities that can be identified through imaging or tissue analysis, and non-structural causes, which relate to systemic conditions or disorders of regulation.⁶

Acronym	Full Term	Category	Brief Description
P	Polyp	Structural	Benign (non-cancerous) growths of the uterine (endometrial) or cervical lining.
A	Adenomyosis	Structural	Endometrial tissue grows into the muscular wall of the uterus (myometrium).
L	Leiomyoma	Structural	Benign tumors of the uterine muscle, commonly known as fibroids.
M	Malignancy & Hyperplasia	Structural	Precancerous (hyperplasia) or cancerous (malignancy) conditions of the endometrium or cervix.
C	Coagulopathy	Non-Structural	Systemic disorders of blood clotting (e.g., von Willebrand disease).
O	Ovulatory Dysfunction	Non-Structural	Hormonal disorders leading to irregular or absent ovulation (e.g., PCOS, thyroid disorders).
E	Endometrial	Non-Structural	Primary disorders of the endometrium, such as inflammation or infection (endometritis).
I	Iatrogenic	Non-Structural	Caused by medical intervention, such as medications (e.g., hormonal contraceptives) or devices (e.g., IUD).
N	Not Yet Classified	Non-Structural	Rare causes or conditions that are not well understood.

Structural Causes of Intermenstrual Bleeding (PALM)

Structural causes of IMB are physical abnormalities within the uterus or cervix that can disrupt the normal architecture and vascularity of the reproductive tract, leading to bleeding.

These conditions are often diagnosed through imaging studies or direct visualization.

Polyps (Cervical and Endometrial)

Polyps are benign (non-cancerous) growths that arise from the mucous membranes lining the uterus (endometrial polyps) or the cervix (cervical polyps).¹

They are attached by a stalk or a broad base and can vary in size from a few millimeters to several centimeters.²³

While often asymptomatic, they can cause a variety of bleeding disturbances, including intermenstrual bleeding or spotting, heavy menstrual periods (

menorrhagia), and bleeding after menopause.¹⁰

Cervical polyps, which may be visible during a speculum exam, are particularly noted for causing bleeding after sexual intercourse (postcoital bleeding) due to their exposed and often fragile nature.⁶

The bleeding from polyps is thought to occur due to surface ulceration or irritation of their delicate blood vessels.

Diagnosis is typically made through transvaginal ultrasound, particularly saline-infusion sonohysterography which enhances visualization of the uterine cavity, or directly via hysteroscopy.⁴

Adenomyosis

Adenomyosis is a condition in which the endometrial glands and stroma—the tissue that normally lines the inside of the uterus—are present within the myometrium, the muscular wall of the uterus.⁷

This ectopic tissue behaves as it would in its proper location: it thickens, breaks down, and bleeds in response to the hormonal fluctuations of the menstrual cycle.¹⁰

Because this bleeding occurs within the muscle wall, it leads to inflammation, uterine enlargement (a “bulky” or “globular” uterus), significant menstrual pain (

dysmenorrhea), and heavy menstrual bleeding.¹⁰

Intermenstrual bleeding can also occur as a result of the disrupted uterine architecture.

Adenomyosis is most commonly diagnosed in women in their later reproductive years, typically in their 40s and 50s.⁶

Diagnosis can be suggested by transvaginal ultrasound but is often more clearly defined with magnetic resonance imaging (MRI).²⁷

Leiomyomas (Uterine Fibroids)

Uterine leiomyomas, more commonly known as fibroids, are extremely common benign tumors that grow in or on the muscular walls of the uterus.¹

They are composed of smooth muscle cells and fibrous connective tissue and can range in size from nearly undetectable to large masses that can distort the shape of the uterus.¹⁸

While fibroids are common, not all cause symptoms.

Their clinical impact, especially their tendency to cause abnormal bleeding, is determined more by their location than their absolute size.

Fibroids are classified based on their location:

• Submucosal fibroids grow just underneath the uterine lining and protrude into the uterine cavity. These are the type most likely to cause significant bleeding issues, including heavy, prolonged periods and intermenstrual bleeding, as they directly affect the endometrium.²¹
• Intramural fibroids grow within the muscular wall of the uterus.
• Subserosal fibroids grow on the outer surface of the uterus.

The presence of submucosal fibroids can increase the surface area of the endometrium, interfere with normal uterine contractility, and disrupt the blood supply, all of which contribute to abnormal bleeding patterns.⁷

Malignancy and Hyperplasia

Although they are the least common causes of intermenstrual bleeding, precancerous and cancerous conditions are the most serious and must be systematically ruled out, especially in certain populations.²

• Endometrial Hyperplasia: This is a precancerous condition characterized by an overgrowth or thickening of the endometrium.⁷ It typically results from prolonged exposure to estrogen without the counterbalancing effects of progesterone, a state known as “unopposed estrogen”.¹⁰ This hormonal imbalance prevents the regular shedding of the uterine lining, allowing it to continue to proliferate. Endometrial hyperplasia is classified based on the appearance of the cells. Hyperplasia
  without atypia involves an overgrowth of normal-looking cells and has a low risk of progressing to cancer.³⁰ However,
  atypical hyperplasia involves an overgrowth of abnormal cells and carries a significantly higher risk of coexisting with or progressing to endometrial cancer.³⁰
• Malignancy: Cancers of the reproductive organs can present with intermenstrual bleeding. These include:

• Endometrial Cancer: The most common gynecologic cancer in many developed countries, it arises from the lining of the uterus. Abnormal bleeding is the presenting symptom in over 90% of cases.⁷
• Cervical Cancer: While often asymptomatic in its early stages, cervical cancer can cause intermenstrual bleeding, postcoital bleeding, and an unusual vaginal discharge.⁷
• Ovarian and Vaginal Cancers: These are rarer causes but can also present with abnormal vaginal bleeding.²

The clinical suspicion for malignancy is heavily influenced by age and risk factors.

While cancer is an uncommon cause of IMB in young women, the risk increases significantly with age.⁶

Any vaginal bleeding in a postmenopausal woman (defined as one year after the final menstrual period) is considered abnormal until proven otherwise and requires immediate and thorough investigation to exclude cancer.¹

Other major risk factors for endometrial cancer include obesity, polycystic ovary syndrome (PCOS), never having given birth, and a history of atypical hyperplasia.⁴

Non-Structural Causes of Intermenstrual Bleeding (COEIN)

Non-structural causes of IMB are not related to physical abnormalities of the uterus but rather to systemic conditions, hormonal dysregulation, or external factors that disrupt the normal function of the menstrual cycle.

Coagulopathy

Coagulopathies are systemic bleeding disorders that impair the body’s ability to form blood clots effectively.¹⁹

While these disorders can cause bleeding throughout the body, they often manifest in women as gynecological bleeding, including heavy menstrual periods and intermenstrual bleeding.³⁸

The most common inherited bleeding disorder is

von Willebrand disease, a condition where there is a deficiency or dysfunction of von Willebrand factor, a protein crucial for platelet adhesion and blood clotting.²

A personal history of heavy bleeding since the first period (menarche), frequent nosebleeds, easy bruising, or prolonged bleeding after dental procedures or surgery should prompt a clinical investigation for an underlying coagulopathy.²¹

Ovulatory and Hormonal Dysfunction

Disruptions to the intricate hormonal symphony that governs the menstrual cycle are among the most frequent causes of intermenstrual bleeding.¹

The cycle is regulated by a complex interplay of hormones from the hypothalamus, pituitary gland, and ovaries (the HPO axis).

Any factor that perturbs this axis can lead to ovulatory dysfunction and abnormal bleeding patterns.

• Physiological Fluctuations: Certain life stages are naturally characterized by hormonal instability and irregular ovulation, making IMB more common.

• Puberty: In the first few years after menarche, the HPO axis is still maturing, often resulting in anovulatory cycles (cycles where an egg is not released) and unpredictable bleeding patterns that can be confused with IMB.¹
• Perimenopause: The transition to menopause, typically occurring in a woman’s 40s, is marked by declining ovarian function and erratic hormone fluctuations. This leads to frequent anovulatory cycles and is a common cause of IMB.¹
• Ovulation Spotting: This is a distinct, benign form of mid-cycle bleeding. It is thought to be caused by the sharp decline in estrogen levels that occurs just after the luteinizing hormone (LH) surge triggers ovulation.⁸ This hormonal shift can temporarily destabilize the endometrial lining, causing a small amount of spotting. It occurs in a minority of women (around 5% or less) and is characterized by very light, pinkish or brownish bleeding that lasts for only a day or two, right in the middle of the menstrual cycle.¹⁶
• Endocrine Disorders: Systemic hormonal conditions are a key cause of ovulatory dysfunction.

• Polycystic Ovary Syndrome (PCOS): PCOS is a common endocrine disorder characterized by an excess of androgens (male hormones) and ovulatory dysfunction.² In PCOS, ovulation occurs infrequently or not at all. This leads to a state of chronic “unopposed estrogen,” where the endometrium is continuously stimulated to grow without the stabilizing influence of progesterone, which is normally produced after ovulation.¹⁰ This unstable, thickened lining can break down and shed unpredictably, causing irregular periods or intermenstrual bleeding.²
• Thyroid Disease: The thyroid gland plays a crucial role in regulating metabolism and interacts closely with reproductive hormones. Both an underactive thyroid (hypothyroidism) and an overactive thyroid (hyperthyroidism) can disrupt the HPO axis, leading to a wide range of menstrual irregularities, including heavy, light, or infrequent periods, as well as IMB.²
• Lifestyle Factors: The HPO axis is highly sensitive to external stressors. Significant physical or emotional stress, drastic changes in diet (such as very low-carbohydrate or ketogenic diets), excessive exercise, and substantial weight gain or loss can all disrupt the hormonal signals from the brain, leading to anovulation and abnormal bleeding.²

Endometrial Causes

This category includes conditions where the primary problem originates within the endometrium itself, often related to inflammation, infection, or a local dysregulation of the mechanisms that control bleeding.

• Endometriosis: In this chronic condition, tissue that is histologically similar to the endometrium grows outside of the uterus, commonly on the ovaries, fallopian tubes, and other pelvic organs.² This ectopic tissue responds to cyclical hormones, causing inflammation, chronic pain, scarring, heavy periods, and sometimes intermenstrual spotting.¹⁸
• Infections and Inflammation: Infections of the reproductive tract can cause inflammation and make tissues fragile and prone to bleeding.

• Endometritis, Cervicitis, and Vaginitis: Inflammation of the uterine lining, cervix, or vagina, respectively, can lead to IMB.⁶ These can be caused by various bacteria or other pathogens. For example, a
  Trichomonas vaginalis infection can cause a characteristic “strawberry cervix” with punctate hemorrhages that bleed easily.⁶
• Pelvic Inflammatory Disease (PID): This is a serious infection of the upper female reproductive organs, including the uterus, fallopian tubes, and ovaries.⁴⁷ PID is typically an ascending infection, often resulting from untreated sexually transmitted infections (STIs) like
  Chlamydia trachomatis or Neisseria gonorrhoeae.¹ The inflammation caused by PID can lead to a range of symptoms, including lower abdominal pain, fever, abnormal and foul-smelling vaginal discharge, pain during intercourse, and irregular bleeding, including IMB and postcoital bleeding.⁴⁷

Iatrogenic Causes

Iatrogenic bleeding is that which is caused by medical examination, treatment, or devices.

This is an exceptionally common category of causes for intermenstrual bleeding.

• Hormonal Contraception: Unscheduled bleeding, often called breakthrough bleeding (BTB), is a very frequent side effect of nearly all forms of hormonal contraception.⁶

• Initiation Phase: BTB is most common during the first 3 to 4 months of starting a new hormonal method, including combined oral contraceptive pills, the patch, the vaginal ring, progestin-only pills, hormonal IUDs, the contraceptive implant, or the injection.⁷ This occurs as the body adjusts to the new hormonal milieu and the endometrium becomes thinner and more stable.⁵¹
• User Behavior: For oral contraceptive users, missing pills or failing to take them at a consistent time each day can cause hormone levels to fluctuate, triggering spotting.⁸
• Formulation: Progestin-only contraceptives (like the “mini-pill,” implant, or hormonal IUD) are more likely to cause irregular spotting than combined estrogen-progestin methods.⁷ Progestin’s primary effect is to thin the endometrial lining. While this is effective for contraception, a very thin, atrophic endometrium can become fragile and prone to spontaneous, irregular shedding and spotting.⁵¹ Low-dose estrogen pills can also have a higher incidence of BTB for similar reasons.⁵¹
• While BTB is often an expected side effect, the new onset of bleeding after several months of stable use on a contraceptive method should prompt an evaluation for other underlying causes, as it may indicate a new problem like an infection or a polyp.¹¹
• Other Medications and Devices:

• Non-hormonal IUDs: The copper IUD is a known cause of heavier menstrual bleeding and can sometimes cause IMB.
• Medications: Several medications can lead to abnormal bleeding. Anticoagulants (blood thinners) like warfarin or apixaban directly interfere with clotting and can cause or worsen vaginal bleeding.⁷ Tamoxifen, a drug used for breast cancer, can have estrogen-like effects on the uterus, leading to polyps, hyperplasia, and bleeding.²⁵ Certain supplements, like St. John’s wort, can decrease the effectiveness of oral contraceptives, leading to BTB.⁵³
• Physical Trauma or Injury: The delicate tissues of the vagina and cervix can be injured, leading to bleeding. This can occur during vigorous sexual intercourse, from the insertion of a foreign object like a tampon, or as a result of a medical procedure such as a Pap smear or pelvic exam.¹

Pregnancy-Related Bleeding

In any person of reproductive age experiencing abnormal vaginal bleeding, pregnancy must be considered as a potential cause until it is definitively ruled O.T.¹

A pregnancy test is therefore a fundamental first step in the diagnostic process.²

• Implantation Bleeding: This is a benign cause of very early pregnancy bleeding. It is thought to occur when the fertilized egg (blastocyst) burrows into the blood-rich lining of the uterus, which can disrupt small blood vessels.¹ Implantation bleeding typically occurs 10 to 14 days after conception, which often coincides with the time an individual would expect their next period.¹³ It is characterized by very light spotting, often pink or brown, that lasts from a few hours to a maximum of three days and is not associated with heavy flow or clots.¹³
• Early Pregnancy Complications: Bleeding during a known or suspected pregnancy can be a sign of a serious complication and requires immediate medical evaluation.¹¹

• Miscarriage (Spontaneous Abortion): This refers to the loss of a pregnancy before the 20th week of gestation. Vaginal bleeding is a common sign of a threatened or actual miscarriage.¹
• Ectopic Pregnancy: This is a potentially life-threatening emergency in which a fertilized egg implants outside of the uterine cavity, most commonly in one of the fallopian tubes.¹ As the pregnancy grows in this confined space, it can cause vaginal bleeding, abdominal pain, and can lead to tubal rupture, a medical emergency causing severe internal bleeding.⁸

The significant overlap between the causes of IMB and conditions that affect fertility and pelvic pain—such as endometriosis, PCOS, fibroids, and PID—underscores the importance of a comprehensive diagnosis.

IMB may be the initial symptom of a condition with broader, long-term implications for an individual’s reproductive health and overall quality of life.

The Clinical Evaluation: A Pathway to Diagnosis

Determining the cause of intermenstrual bleeding requires a systematic and logical diagnostic approach.

The process is a tiered cascade, beginning with the least invasive methods—a detailed patient history and physical examination—and progressing to laboratory tests, imaging, and more invasive procedures only as clinically indicated.

This pathway is designed to be both efficient and patient-centered, ensuring that serious conditions are identified while avoiding unnecessary testing.

The Importance of a Detailed Medical History

The cornerstone of any evaluation for IMB is a thorough medical history, as the patient’s own account of their symptoms provides crucial clues that guide the subsequent investigation.³

A healthcare provider will likely ask detailed questions covering several key areas:

• Characteristics of the Bleeding: The provider will want to understand the nature of the bleeding itself, including its timing within the cycle, frequency (is it a one-time event or recurring?), duration, and volume (e.g., how many pads/tampons are used, are there clots, and what is their size?).³
• Menstrual History: Details such as the age of the first period (menarche), the typical length and regularity of menstrual cycles, and the date of the last menstrual period help establish a baseline of what is “normal” for the individual.³
• Associated Symptoms: The presence of other symptoms can point toward specific diagnoses. These include pelvic pain or cramping, fever, dizziness, fatigue, unusual vaginal discharge (noting its color, consistency, and odor), and pain during or after sexual intercourse (postcoital bleeding).¹
• Sexual and Reproductive History: This includes questions about sexual activity, the number of partners, contraceptive methods used (past and present), the possibility of pregnancy, and the history of past pregnancies and their outcomes. A history of STIs and the status of routine cervical cancer screening (Pap smears) are also important.³
• Medications and Lifestyle: A complete list of all medications—including hormonal contraceptives, anticoagulants, and over-the-counter drugs like NSAIDs—as well as any herbal supplements is essential, as many can cause or contribute to abnormal bleeding.³ The provider may also ask about recent changes in stress levels, diet, or exercise habits.²
• Past Medical and Family History: A history of conditions like thyroid disorders, PCOS, or bleeding disorders (in the patient or their family) is highly relevant.³

The Physical and Pelvic Examination

Following the history, a physical examination is performed to look for signs of underlying systemic or gynecological issues.

• General Examination: The provider will assess vital signs and look for signs of anemia (like pale skin), thyroid gland enlargement, or evidence of a bleeding disorder (such as easy bruising or petechiae). Signs of hormonal imbalance, like acne or excess hair growth (hirsutism), may also be noted.³
• Pelvic Examination: This is a crucial part of the evaluation.

• A speculum exam allows for direct visual inspection of the vaginal walls and cervix. The provider will look for any lesions, growths (like cervical polyps), inflammation, signs of trauma, or abnormal discharge.²
• A bimanual exam, where the provider places two fingers inside the vagina while pressing on the lower abdomen with the other hand, is used to assess the size, shape, and mobility of the uterus and ovaries. This can help detect uterine enlargement (as seen in adenomyosis or large fibroids), pelvic masses, or tenderness that might suggest an infection like PID.⁶

Laboratory and Imaging Studies

Based on the history and physical exam, a provider will order specific tests to narrow down the potential causes.

• Initial Laboratory Tests:

• Pregnancy Test: A urine or blood test for human chorionic gonadotropin (hCG) is almost always the first step to definitively rule out pregnancy and its potential complications.²
• STI Screening: Samples are often collected during the pelvic exam to test for common infections like Chlamydia trachomatis and Neisseria gonorrhoeae, which are frequent causes of cervicitis and PID.²
• Complete Blood Count (CBC): This blood test measures hemoglobin and hematocrit levels to determine if chronic or heavy bleeding has led to anemia.²

• Hormonal and Coagulation Panels: If an endocrine disorder or bleeding disorder is suspected, blood tests can be ordered to measure levels of thyroid-stimulating hormone (TSH), prolactin, and other reproductive hormones. A coagulation panel, including tests for von Willebrand factor, may be performed if the patient’s history is suggestive of a coagulopathy.²
• Imaging Modalities:

• Transvaginal Ultrasound: This is the first-line imaging study for evaluating the pelvic organs. A small ultrasound probe is placed in the vagina to provide high-resolution images of the uterus, endometrial lining, and ovaries. It is excellent for identifying structural abnormalities like fibroids and adenomyosis and can measure the thickness of the endometrium.²
• Saline-Infusion Sonohysterography (SIS): For a more detailed view of the uterine cavity, an SIS may be performed. In this procedure, a small amount of sterile saline is infused into the uterus during a transvaginal ultrasound. The fluid gently distends the uterine cavity, allowing for much clearer visualization of the endometrial lining and the detection of subtle abnormalities like endometrial polyps or submucosal fibroids that might be missed on a standard ultrasound.¹⁹
• Magnetic Resonance Imaging (MRI): MRI is not a routine test for IMB but may be used in specific situations, such as to get a more precise map of large or numerous fibroids before surgery or to better characterize suspected adenomyosis.²⁴

Tissue Sampling and Direct Visualization

When imaging suggests an abnormality within the uterine lining or if there is a high suspicion of hyperplasia or malignancy, obtaining a tissue sample for histological analysis is necessary.

• Endometrial Biopsy: This is a common office procedure where a thin, flexible tube (a Pipelle) is passed through the cervix into the uterus to suction out a small sample of the endometrial lining. The tissue is then examined by a pathologist. A biopsy is strongly recommended for all postmenopausal women with bleeding and for women over 45 with new-onset IMB. It is also indicated for younger women with persistent bleeding or specific risk factors for endometrial cancer, such as obesity or PCOS.⁴
• Hysteroscopy: Often considered the gold standard for evaluating the inside of the uterus, hysteroscopy involves inserting a thin, lighted camera (hysteroscope) through the cervix.⁴ This allows the provider to directly visualize the entire endometrial cavity and identify any polyps, fibroids, or other suspicious areas. A key advantage of hysteroscopy is that it allows for targeted biopsies of specific lesions and can often be used to treat the problem at the same time (a “see-and-treat” approach), such as by removing a polyp or small fibroid.⁴
• Dilation and Curettage (D&C): In this surgical procedure, the cervix is dilated, and an instrument called a curette is used to scrape tissue from the uterine lining. While historically used for both diagnosis and treatment, a “blind” D&C is less accurate for diagnosing focal lesions than hysteroscopy. It is now often performed in conjunction with hysteroscopy to ensure the entire cavity is evaluated and treated.³

Management and Therapeutic Strategies

The management of intermenstrual bleeding is not a one-size-fits-all approach.

Treatment is tailored specifically to the underlying diagnosis, as well as the patient’s age, severity of symptoms, desire for future fertility, and personal preferences.

The primary goal is to address the root cause of the bleeding, thereby resolving the symptom.³

Medical Management

For many non-structural causes of IMB, medical therapy is the first line of treatment.

• Hormonal Regulation: Medications that regulate the hormonal cycle are highly effective for bleeding caused by ovulatory dysfunction (like in PCOS), endometriosis, adenomyosis, and for managing breakthrough bleeding on contraception.

• Combined Hormonal Contraceptives (CHCs): Birth control pills, the patch, and the vaginal ring contain both estrogen and progestin. They work by suppressing ovulation and providing a stable hormonal environment, which thins the endometrium and leads to lighter, more predictable withdrawal bleeds.¹⁰ They are often used to manage the irregular bleeding associated with PCOS and endometriosis.⁶³
• Progestin-Only Therapy: Progestins are synthetic forms of progesterone. They are highly effective at counteracting the proliferative effects of estrogen on the endometrium, causing it to thin and stabilize. This makes them a primary treatment for endometrial hyperplasia without atypia, adenomyosis, and for women who cannot take estrogen.¹⁹ Progestins can be administered as oral tablets, long-acting injections (Depo-Provera), a contraceptive implant (Nexplanon), or through a
  levonorgestrel-releasing intrauterine device (IUD). The hormonal IUD is particularly effective for managing heavy bleeding from causes like adenomyosis or fibroids, as it delivers the hormone directly to the uterine lining.¹⁹
• Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists: These powerful medications temporarily shut down ovarian hormone production, inducing a state of “medical menopause.” They are used short-term to shrink fibroids before surgery or to suppress severe endometriosis.³
• Non-Hormonal Medications:

• Tranexamic Acid: This medication works by stabilizing blood clots and preventing their premature breakdown (antifibrinolytic). It is highly effective at reducing the volume of menstrual blood loss and is taken only on the days of heavy bleeding. It is a good option for those who cannot or do not wish to use hormonal treatments.³
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Medications like ibuprofen and naproxen, when started a day or two before the period and continued through the first few days, can decrease menstrual blood flow by up to 25-35% and also help relieve menstrual cramps.³

• Antibiotic Therapy: For IMB caused by infections such as chlamydia, gonorrhea, or Pelvic Inflammatory Disease (PID), a course of broad-spectrum antibiotics is the definitive treatment.⁹ According to CDC guidelines, PID treatment should be initiated promptly to cover likely pathogens and prevent long-term complications like chronic pelvic pain, ectopic pregnancy, and infertility. Treatment typically involves a combination of antibiotics for 14 days, and sexual partners must also be treated to prevent reinfection.⁴⁷
• Management of Systemic Conditions:

• Thyroid Disorders: Correcting the underlying thyroid imbalance with medication—levothyroxine for hypothyroidism or anti-thyroid drugs for hyperthyroidism—will typically resolve the associated menstrual irregularities.⁷⁴
• Bleeding Disorders: For women with von Willebrand disease, treatment options to control heavy bleeding include desmopressin (DDAVP), which boosts the release of clotting factors; clot-stabilizing medications like tranexamic acid; hormonal contraceptives to increase factor levels; or, in severe cases, infusions of clotting factor concentrates.⁶⁰

Surgical and Procedural Interventions

When medical therapy is ineffective, not tolerated, or when a distinct structural abnormality is the cause of bleeding, surgical or procedural interventions may be necessary.

• Hysteroscopic Procedures: These minimally invasive procedures are performed using a scope passed through the cervix. They are the standard of care for removing intrauterine growths like endometrial polyps (polypectomy) or submucosal fibroids (myomectomy). This approach is highly effective and preserves the uterus.³
• Endometrial Ablation: This procedure destroys the endometrial lining using energy sources like heat, freezing, or radiofrequency. It significantly reduces or eliminates menstrual bleeding but is only suitable for individuals who have completed childbearing, as it can compromise future pregnancies.³ It is not considered a first-line therapy for AUB associated with ovulatory dysfunction.¹⁹
• Uterine Artery Embolization (UAE): A radiologic procedure where tiny particles are injected into the arteries supplying the uterus, blocking blood flow to fibroids. This starves the fibroids, causing them to shrink and symptoms to resolve. It is a uterus-sparing option for those who may not be ideal surgical candidates.³
• Myomectomy: The surgical removal of uterine fibroids while leaving the uterus in place. This is the preferred surgical option for individuals with symptomatic fibroids who wish to preserve their fertility.³
• Hysterectomy: The surgical removal of the uterus is the only definitive cure for many causes of AUB originating from the uterus, such as adenomyosis or intractable fibroids. It is a major surgery that results in the inability to become pregnant and is generally reserved for cases where other treatments have failed, are not desired, or when cancer is present.³

Condition-Specific Treatment Modalities

Condition	First-Line Medical Treatments	Second-Line / Procedural Treatments	Definitive Treatment
Uterine Fibroids	Hormonal contraceptives (CHCs, progestin IUD), Tranexamic acid, NSAIDs, GnRH agonists (short-term) 10	Uterine Artery Embolization (UAE), Myomectomy (laparoscopic, hysteroscopic, or abdominal) 3	Hysterectomy 3
PCOS	Lifestyle changes (weight loss, diet), Combined hormonal contraceptives, Progestin therapy (cyclic or continuous) 63	Metformin (especially with insulin resistance) 63	Not applicable; management is chronic.
Adenomyosis	Progestin-releasing IUD, Combined hormonal contraceptives, NSAIDs for pain 72	Uterine Artery Embolization (less common), Endometrial ablation (for bleeding only, not underlying cause) 86	Hysterectomy 26
Endometrial Hyperplasia (without atypia)	Progestin therapy (oral, IUD, injection) to thin the endometrium 30	Dilation and Curettage (D&C) for acute bleeding 55	Hysterectomy (if fertility is not desired or progestin therapy fails) 31
Endometrial Hyperplasia (with atypia)	Hysterectomy is the standard of care due to high risk of underlying or future cancer 31	High-dose progestin therapy (if fertility preservation is critical and with close monitoring) 32	Hysterectomy 32
Pelvic Inflammatory Disease (PID)	Broad-spectrum antibiotics (e.g., ceftriaxone + doxycycline + metronidazole) for 14 days, treatment of sexual partners 47	Hospitalization for intravenous antibiotics if severe 49	Surgical drainage of abscess if present and unresponsive to antibiotics 47

Conclusion: Key Takeaways and When to Seek Professional Medical Advice

Intermenstrual bleeding is a complex symptom with a broad differential diagnosis that spans benign physiological events, systemic diseases, and serious gynecological pathology.

Understanding the potential causes and the systematic approach to diagnosis is the first step toward effective management.

The most critical takeaway is that while IMB is common and often not a sign of a serious problem, it should never be ignored.

The baseline for what constitutes “normal” is highly individual, and any significant change from one’s personal, established menstrual pattern warrants attention.

Red Flag Symptoms: When to Seek Medical Care

While any persistent or concerning IMB should be discussed with a healthcare provider, certain signs and symptoms indicate a need for more urgent medical evaluation.

Seek Immediate or Urgent Medical Care if:

• You are pregnant or could be pregnant and experience any vaginal bleeding. This is crucial to rule out ectopic pregnancy or miscarriage.¹
• The bleeding is extremely heavy, defined as soaking through at least one pad or tampon per hour for two or more consecutive hours.¹⁰
• The bleeding is accompanied by other severe symptoms, such as intense pelvic or abdominal pain, dizziness, lightheadedness, fainting, fever, or chills.¹

Schedule an Appointment with a Healthcare Provider if:

• You experience any vaginal bleeding after menopause. This is never considered normal and requires a thorough evaluation to rule out malignancy.¹
• The intermenstrual bleeding is a new pattern that occurs repeatedly over several months.¹
• You consistently experience bleeding or spotting after sexual intercourse (postcoital bleeding).¹
• The bleeding is accompanied by other concerning symptoms, such as unusual or foul-smelling vaginal discharge, persistent pelvic pain, easy bruising, or unexplained fatigue.¹
• You are over the age of 45 and develop new-onset intermenstrual bleeding.¹

Empowerment Through Knowledge

This report provides a comprehensive map of the potential causes and clinical pathways related to intermenstrual bleeding.

However, it is not a substitute for a professional medical diagnosis.

The most valuable tool in achieving an accurate diagnosis is a collaborative partnership with a healthcare provider.

By tracking the timing, volume, and characteristics of bleeding episodes, along with any associated symptoms, an individual can provide their doctor with the precise information needed to navigate the diagnostic process efficiently and effectively.¹¹

This proactive approach, combined with the knowledge of when to seek care, empowers individuals to take control of their reproductive health and ensure that any underlying conditions are identified and managed appropriately.

Works cited

1. 10 common causes of Intermenstrual bleeding (IMB) – Pharma Dynamics, accessed August 12, 2025, https://www.mydynamics.co.za/health_post/intermenstrual-bleeding/
2. Intermenstrual Bleeding – 3W Medical for Women, accessed August 12, 2025, https://www.3wmedical.org/medical-blog/intermenstrual-bleeding
3. Abnormal Uterine Bleeding – StatPearls – NCBI Bookshelf, accessed August 12, 2025, https://www.ncbi.nlm.nih.gov/books/NBK532913/
4. ACOG Practice Bulletin. Diagnosis of abnormal uterine bleeding in reproductive-aged women. – ResearchGate, accessed August 12, 2025, https://www.researchgate.net/publication/230766473_ACOG_Practice_Bulletin_Diagnosis_of_abnormal_uterine_bleeding_in_reproductive-aged_women
5. files-profile.medicine.yale.edu, accessed August 12, 2025, https://files-profile.medicine.yale.edu/documents/72af801d-3b76-4a1e-82a6-b27adf7b5141#:~:text=According%20to%20ACOG%2C%20%22Abnormal%20uterine,with%20cycles%20between%2021%20and
6. Intermenstrual and Postcoital Bleeding | Doctor – Patient.info, accessed August 12, 2025, https://patient.info/doctor/intermenstrual-and-postcoital-bleeding
7. Intermenstrual bleeding – Wikipedia, accessed August 12, 2025, https://en.wikipedia.org/wiki/Intermenstrual_bleeding
8. Abnormal Pain and Menstrual Bleeding Spotting Between Periods, accessed August 12, 2025, https://www.yourperiod.ca/abnormal-pain-and-menstrual-bleeding/spotting-between-periods/
9. Spotting vs. Periods: What’s the Difference? – Orlando Health, accessed August 12, 2025, https://www.orlandohealth.com/content-hub/spotting-vs-periods
10. Heavy menstrual bleeding – Symptoms and causes – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/menorrhagia/symptoms-causes/syc-20352829
11. Spotting vs. period: Differences and common causes, accessed August 12, 2025, https://www.medicalnewstoday.com/articles/317595
12. Vaginal bleeding – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/symptoms/vaginal-bleeding/basics/definition/sym-20050756
13. What is Implantation Bleeding? – American Pregnancy Association, accessed August 12, 2025, https://americanpregnancy.org/pregnancy-symptoms/what-is-implantation-bleeding/
14. What Is Ovulation Bleeding and How Do You Identify It? – Verywell Health, accessed August 12, 2025, https://www.verywellhealth.com/ovulation-bleeding-5182477
15. Implantation Bleeding: Causes, Symptoms & What To Expect, accessed August 12, 2025, https://my.clevelandclinic.org/health/symptoms/24536-implantation-bleeding
16. Bleeding During Ovulation | Causes And What It Might Mean, accessed August 12, 2025, https://tidewaterobgyn.com/bleeding-during-ovulation/
17. Vaginal Bleeding Between Periods: Causes, Prevention & Diagnosis, accessed August 12, 2025, https://www.healthline.com/health/vaginal-bleeding-between-periods
18. 5 Causes of Bleeding Between Periods – Daniel Esteves, MD, accessed August 12, 2025, https://www.wsong.org/blog/5-causes-of-bleeding-between-periods
19. ACOG Releases Guidelines on Management of Abnormal Uterine Bleeding Associated with Ovulatory Dysfunction | AAFP, accessed August 12, 2025, https://www.aafp.org/pubs/afp/issues/2014/0615/p987.html
20. ACOG Guidelines at a Glance: Bulletin on AUB-O: Much-Needed Updates, accessed August 12, 2025, https://www.contemporaryobgyn.net/view/acog-guidelines-glance-bulletin-aub-o-much-needed-updates
21. Evaluation and Management of Abnormal Uterine Bleeding in Premenopausal Women, accessed August 12, 2025, https://www.aafp.org/pubs/afp/issues/2012/0101/p35.html
22. Abnormal Uterine Bleeding: An Age Based Approach – ACOFP, accessed August 12, 2025, https://acofp.org/docs/default-source/ofp/vol-10-no-6-(2018)-november-december-2018/abnormal-uterine-bleeding-an-age-based-approach.pdf?sfvrsn=23e86226_0
23. Uterine polyps – Symptoms & causes – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/uterine-polyps/symptoms-causes/syc-20378709
24. Abnormal Vaginal Bleeding – Evaluation and Treatment – Radiologyinfo.org, accessed August 12, 2025, https://www.radiologyinfo.org/en/info/vaginalbleeding
25. Vaginal bleeding Causes – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/symptoms/vaginal-bleeding/basics/causes/sym-20050756
26. Adenomyosis: Causes, Symptoms, Diagnosis & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/14167-adenomyosis
27. Abnormal Uterine Bleeding patient education booklet | ReproductiveFacts.org, accessed August 12, 2025, https://www.reproductivefacts.org/news-and-publications/fact-sheets-and-infographics/abnormal-uterine-bleeding-booklet2/
28. Hysteroscopic Polypectomy and Myomectomy – Tampa General Hospital, accessed August 12, 2025, https://www.tgh.org/institutes-and-services/treatments/hysteroscopic-polypectomy-myomecomty
29. 6 Medical Causes of Spotting Between Periods – OBGYN Westside, PLLC, accessed August 12, 2025, https://www.obgynwestside.com/blog/6-medical-causes-of-spotting-between-periods
30. Endometrial Hyperplasia: Causes, Symptoms & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/16569-atypical-endometrial-hyperplasia
31. Endometrial Hyperplasia: Symptoms, Causes & Treatment – Kent Kuswanto, accessed August 12, 2025, https://drkentkuswanto.com.au/endometrial-hyperplasia-what-you-should-know/
32. Endometrial Atypical Hyperplasia – Chelsea and Westminster Hospital, accessed August 12, 2025, https://www.chelwest.nhs.uk/your-visit/patient-leaflets/womens-services/endometrial-atypical-hyperplasia
33. Endometrial Cancer Signs, Symptoms, & Risk Factors | OurWayForward.com, accessed August 12, 2025, https://ourwayforward.com/endometrial-cancer/signs-symptoms-risk-factors/
34. Cervical Cancer Symptoms – NCI, accessed August 12, 2025, https://www.cancer.gov/types/cervical/symptoms
35. Cervical Cancer Symptoms – Cancer Research UK, accessed August 12, 2025, https://www.cancerresearchuk.org/about-cancer/cervical-cancer/symptoms
36. Symptoms of Ovarian Cancer – CDC, accessed August 12, 2025, https://www.cdc.gov/ovarian-cancer/symptoms/index.html
37. Vaginal bleeding When to see a doctor – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/symptoms/vaginal-bleeding/basics/when-to-see-doctor/sym-20050756
38. Bleeding between periods | healthdirect, accessed August 12, 2025, https://www.healthdirect.gov.au/bleeding-between-periods
39. EVALUATION OF ABNORMAL UTERINE BLEEDING: NON-STRUCTURAL ETIOLOGIES, accessed August 12, 2025, https://www.obgyn.columbia.edu/file/23290/download?token=IlRwGmlz
40. helloclue.com, accessed August 12, 2025, https://helloclue.com/articles/cycle-a-z/ovulation-bleeding-what-it-is-how-to-know-if-youre-experiencing-it#:~:text=Ovulation%20spotting%20happens%20during%20ovulation,or%20fewer%20people%20(4).
41. Ovulation bleeding and ovulation spotting: What it is, & why it happens – Clue app, accessed August 12, 2025, https://helloclue.com/articles/cycle-a-z/ovulation-bleeding-what-it-is-how-to-know-if-youre-experiencing-it
42. Irregular Periods (Abnormal Menstruation): Causes & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/14633-abnormal-menstruation-periods
43. Options for Managing Periods with PCOS | Children’s Hospital Colorado, accessed August 12, 2025, https://www.childrenscolorado.org/globalassets/departments/gynecology/informational-pdfs/options-for-managing-periods-with-pcos.pdf?v=490a55
44. Thyroid disease – Women’s Health.gov, accessed August 12, 2025, https://womenshealth.gov/a-z-topics/thyroid-disease
45. Thyroid Disorders in Women | Johns Hopkins Medicine, accessed August 12, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/thyroid-disorders-in-women
46. Understanding Intermenstrual Bleeding: Causes, Symptoms & Treatment – Megawecare, accessed August 12, 2025, https://www.megawecare.com/good-health-by-yourself/menstrual-health/intermenstrual-bleeding-vaginal-bleeding-between-periods
47. Pelvic Inflammatory Disease (PID): Symptoms & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/9129-pelvic-inflammatory-disease-pid
48. Pelvic inflammatory disease – NHS, accessed August 12, 2025, https://www.nhs.uk/conditions/pelvic-inflammatory-disease-pid/
49. Pelvic Inflammatory Disease – StatPearls – NCBI Bookshelf, accessed August 12, 2025, https://www.ncbi.nlm.nih.gov/books/NBK499959/
50. Pelvic Inflammatory Disease (PID) | Johns Hopkins Medicine, accessed August 12, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/pelvic-inflammatory-disease-pid
51. Why am I spotting on birth control? 8 possible reasons why – Flo, accessed August 12, 2025, https://flo.health/menstrual-cycle/sex/birth-control/spotting-on-birth-control
52. Birth Control Pills and Bleeding – AAFP, accessed August 12, 2025, https://www.aafp.org/pubs/afp/issues/2002/0515/p2083.html
53. Extended-cycle birth control pills: Is spotting common? – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/tests-procedures/combination-birth-control-pills/expert-answers/seasonale-side-effects/faq-20058109
54. How to stop spotting on birth control pills – Medical News Today, accessed August 12, 2025, https://www.medicalnewstoday.com/articles/322840
55. Abnormal Uterine Bleeding: Causes, Diagnosis & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/menometrorrhagia-abnormal-uterine-bleeding
56. Abnormal Uterine Bleeding Clinical Pathway – Johns Hopkins Medicine, accessed August 12, 2025, https://www.hopkinsmedicine.org/-/media/files/allchildrens/clinical-pathways/2024-abnormal-uterine-bleeding-clinical-pathway-8_22_2024.pdf
57. ABNORMAL UTERINE BLEEDING, accessed August 12, 2025, https://files-profile.medicine.yale.edu/documents/72af801d-3b76-4a1e-82a6-b27adf7b5141
58. Abnormal Uterine Bleeding Treatment – University of Colorado OB-GYN Women’s Health, accessed August 12, 2025, https://obgyn.coloradowomenshealth.com/services/abnormal-bleeding-treatment
59. Medical management of abnormal uterine bleeding in reproductive-age women | MDedge, accessed August 12, 2025, https://blogs.the-hospitalist.org/content/medical-management-abnormal-uterine-bleeding-reproductive-age-women
60. Von Willebrand disease – Diagnosis & treatment – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/von-willebrand-disease/diagnosis-treatment/drc-20354984
61. Vaginal bleeding – hormonal Information | Mount Sinai – New York, accessed August 12, 2025, https://www.mountsinai.org/health-library/diseases-conditions/vaginal-bleeding-hormonal
62. www.mayoclinic.org, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/menorrhagia/diagnosis-treatment/drc-20352834#:~:text=Dilation%20and%20curettage%2C%20also%20called%20a%20D%26C.&text=This%20also%20is%20known%20as,to%20completely%20empty%20the%20uterus.
63. Polycystic ovary syndrome (PCOS) – Diagnosis and treatment – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443
64. Vaginal or uterine bleeding: MedlinePlus Medical Encyclopedia, accessed August 12, 2025, https://medlineplus.gov/ency/article/007496.htm
65. Endometriosis: Causes, Symptoms, Diagnosis & Treatment – Cleveland Clinic, accessed August 12, 2025, https://my.clevelandclinic.org/health/diseases/10857-endometriosis
66. Medical Treatments for Endometriosis – Brigham and Women’s Hospital, accessed August 12, 2025, https://www.brighamandwomens.org/obgyn/infertility-reproductive-surgery/endometriosis/medical-treatment-for-endometriosis
67. Progesterone Treatment for Endometrial Hyperplasia Side Effects – Rylon Clinic, accessed August 12, 2025, https://www.rylonclinic.com/post/progesterone-treatment-for-endometrial-hyperplasia-side-effects
68. Diagnosis, Symptoms, and Treatment of Fibroids and Polyps | Progyny, accessed August 12, 2025, https://progyny.com/education/diagnosis-symptoms-treatment-fibroids-polyps/
69. Menorrhagia (heavy menstrual bleeding) – UCHealth, accessed August 12, 2025, https://www.uchealth.org/diseases-conditions/menorrhagia/
70. Von Willebrand Disorder (VWD) – Special Issues for Women and Girls, accessed August 12, 2025, https://www.haemophilia.org.au/national-haemophilia/no-187-september-2014/von-willebrand-disorder-vwd-special-issues-for/
71. Tranexamic Acid Offers Better Control of Heavy Menstrual Bleeding in Patients with Von Willebrand Disease – Consult QD, accessed August 12, 2025, https://consultqd.clevelandclinic.org/tranexamic-acid-offers-better-control-of-heavy-menstrual-bleeding-in-patients-with-von-willebrand-disease
72. Adenomyosis: Diagnosis and Management – AAFP, accessed August 12, 2025, https://www.aafp.org/pubs/afp/issues/2022/0100/p33.html
73. Pelvic Inflammatory Disease (PID) – STI Treatment Guidelines – CDC, accessed August 12, 2025, https://www.cdc.gov/std/treatment-guidelines/pid.htm
74. Does Thyroid Medication Affect The Menstrual Cycle? – Everlywell, accessed August 12, 2025, https://www.everlywell.com/blog/thyroid/does-thyroid-medication-affect-menstrual-cycle/
75. Does Hypothyroidism Affect Menstrual Periods? Things to Know – Healthline, accessed August 12, 2025, https://www.healthline.com/health/does-hypothyroidism-affect-period
76. www.mayoclinic.org, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/von-willebrand-disease/diagnosis-treatment/drc-20354984#:~:text=Your%20doctor%20might%20suggest%20one,as%20an%20injection%20(DDAVP).
77. Fibroids & Polyps – Dr Jenny Cook, accessed August 12, 2025, https://www.drjennycook.com/fibroids-and-polyps
78. Uterine fibroids – Diagnosis and treatment – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/uterine-fibroids/diagnosis-treatment/drc-20354294
79. Polyp vs. Fibroid: Symptoms, Treatment, FAQs, and More – Healthline, accessed August 12, 2025, https://www.healthline.com/health/womens-health/polyp-vs-fibroid
80. Adenomyosis – Diagnosis & treatment – Mayo Clinic, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/adenomyosis/diagnosis-treatment/drc-20369143
81. Endometriosis vs. PCOS: Symptoms, Diagnosis, Treatment – Healthline, accessed August 12, 2025, https://www.healthline.com/health/womens-health/endometriosis-vs-pcos
82. Treatment : Polycystic ovary syndrome – NHS, accessed August 12, 2025, https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/treatment/
83. A PATIENT’S GUIDE: Polycystic Ovary Syndrome (PCOS) – PMC, accessed August 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5393469/
84. Adenomyosis | Johns Hopkins Medicine, accessed August 12, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/adenomyosis
85. www.mayoclinic.org, accessed August 12, 2025, https://www.mayoclinic.org/diseases-conditions/adenomyosis/diagnosis-treatment/drc-20369143#:~:text=Hormone%20medications.,and%20pain%20associated%20with%20adenomyosis.
86. Adenomyosis | Endometriosis Treatment Center of America, accessed August 12, 2025, https://www.centerofendometriosis.com/endometriosis-services/adenomyosis/
87. www.yalemedicine.org, accessed August 12, 2025, https://www.yalemedicine.org/conditions/endometrial-hyperplasia#:~:text=How%20is%20endometrial%20hyperplasia%20treated,minimize%20symptoms%20of%20endometrial%20hyperplasia.
88. Therapeutic options for management of endometrial hyperplasia – PMC – PubMed Central, accessed August 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4695458/